NEW YORK--(BUSINESS WIRE)--Massive Bio, Inc., a leader in precision medicine and artificial intelligence (AI)-enabled patient-centric oncology clinical trial enrollment, announced today it has ...
LONDON – Oxford University spinout Oxdx Ltd. has raised £2.6 million (US$3.6 million) in pre-seed funding to advance development of a technology for directly identifying infectious pathogens without ...
Cancer Research Technology Ltd. and My-T Bio Ltd. have jointly developed biarylamide derivatives acting as membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (PKMYT1) ...
ProteinChip proteomics technology can accelerate the discovery of protein biomarkers, including tumor markers. ProteinChip technology incorporates surface-enhanced laser desorption/ionization with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback